Latest filing published 02 Apr 2021 for Intellia Therapeutics, Inc., €389k.
Filing timeline
BuySaleInsider track record
Jose E. Rivera: trading record in brief
Jose E. Rivera discloses dealings in Intellia Therapeutics, Inc. to SEC (Form 4). Between 1 June 2017 and 1 April 2021, the trades on record add up to 68 filings.
Every open-market trade on record is a sale: 47 sales worth €8.2M. Outside the open market, there are 1 share grant and 20 option exercises. 2021 to date brings no purchases and 32 sales.
Most recently, on 2 April 2021, the filings show an option exercise worth €389k in Intellia Therapeutics, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Jose E. Rivera
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 33,000 shares@ US$13.883.5% of flowCommon StockSEC:0001209191-21-024888:0
- 2,010 shares@ US$80.791.2% of flowCommon StockSEC:0001209191-21-024888:1
- 8,266 shares@ US$81.895.2% of flowCommon StockSEC:0001209191-21-024888:2
- 3,233 shares@ US$82.762.0% of flowCommon StockSEC:0001209191-21-024888:3
- 3,234 shares@ US$83.912.1% of flowCommon StockSEC:0001209191-21-024888:4
- 1,067 shares@ US$84.940.7% of flowCommon StockSEC:0001209191-21-024888:5
- 21,000 shares@ US$18.302.9% of flowCommon StockSEC:0001209191-21-024888:6
- 1,256 shares@ US$80.820.8% of flowCommon StockSEC:0001209191-21-024888:7
- 4,818 shares@ US$81.833.0% of flowCommon StockSEC:0001209191-21-024888:8
- 2,728 shares@ US$82.631.7% of flowCommon StockSEC:0001209191-21-024888:9
- 1,724 shares@ US$83.721.1% of flowCommon StockSEC:0001209191-21-024888:10
- 963 shares@ US$84.870.6% of flowCommon StockSEC:0001209191-21-024888:11
- 10,000 shares@ US$14.581.1% of flowCommon StockSEC:0001209191-21-024888:12
- 700 shares@ US$80.730.4% of flowCommon StockSEC:0001209191-21-024888:13
- 2,644 shares@ US$81.951.7% of flowCommon StockSEC:0001209191-21-024888:14
- 951 shares@ US$82.870.6% of flowCommon StockSEC:0001209191-21-024888:15
- 1,049 shares@ US$83.980.7% of flowCommon StockSEC:0001209191-21-024888:16
- 123 shares@ US$85.140.1% of flowCommon StockSEC:0001209191-21-024888:17
- 33,001 shares@ US$6.831.7% of flowCommon StockSEC:0001209191-21-024888:18
- 1,965 shares@ US$80.851.2% of flowCommon StockSEC:0001209191-21-024888:19
- 6,768 shares@ US$81.874.2% of flowCommon StockSEC:0001209191-21-024888:20
- 3,361 shares@ US$82.772.1% of flowCommon StockSEC:0001209191-21-024888:21
- 2,258 shares@ US$83.851.4% of flowCommon StockSEC:0001209191-21-024888:22
- 1,213 shares@ US$84.730.8% of flowCommon StockSEC:0001209191-21-024888:23
- 124 shares@ US$85.760.1% of flowCommon StockSEC:0001209191-21-024888:24
25 of 68 declarations